Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

(2013) Edward J. Mills et al.   ANNALS OF INTERNAL MEDICINE

Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa

(2011) Michael Abouyannis et al.   AIDS

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa

(2011) Julie H Levison et al.   ANTIVIRAL THERAPY

Drug Resistance Profiles Among HIV-1–Infected Children Experiencing Delayed Switch and 12-Month Efficacy After Using Second-Line Antiretroviral Therapy: An Observational Cohort Study in Rural China

(2011) Yan Zhao et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Low Lopinavir Plasma or Hair Concentrations Explain Second-Line Protease Inhibitor Failures in a Resource-Limited Setting

(2011) Gert Uves van Zyl et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

(2011) Kim C E Sigaloff et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

(2011) Raph L Hamers et al.   LANCET INFECTIOUS DISEASES

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

(2011) Ellen 't Hoen et al.   Journal of the International AIDS Society

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

(2011) Laurent Ferradini et al.   Journal of the International AIDS Society

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

(2010) Andrew Boulle et al.   AIDS

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa

(2010) Ziad El-Khatib et al.   AIDS

The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa

(2010) Lawrence Long et al.   AIDS

Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting

(2010) Krittaecho Siripassorn et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited Setting

(2010) G. U. van Zyl et al.   CLINICAL INFECTIOUS DISEASES

High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa

(2010) Matthew P Fox et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness

(2010) April D Kimmel et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries

(2010) Mar Pujades-Rodríguez   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire

(2010) Armelle Pasquet et al.   PLoS One

Mortality after failure of antiretroviral therapy in sub-Saharan Africa

(2010) Olivia Keiser et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Clinical experience with the combined use of lopinavir/ritonavir and rifampicin

(2009) Rafaëlla FA Lʼhomme et al.   AIDS

HIV protease inhibitors: recent clinical trials and recommendations on use

(2009) José Vicente Fernández-Montero et al.   EXPERT OPINION ON PHARMACOTHERAPY

Antiretroviral roll-out: the problem of second-line therapy

(2009) Mark Boyd et al.   LANCET

Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population

(2008) Krishnan Bhaskaran   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

(2008) Andreas Jahn et al.   LANCET

HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand

(2008) David Wilson et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE